Bankrupt genetic analysis company 23andMe will hold a second auction for its cache of DNA data with an opening bid of $305 million from a group led by the company’s former chief executive officer, Anne Wojcicki.

Bankrupt genetic testing company 23andMe is looking to sell its assets — most notably its customers' DNA data — for more than $300 million. The company told a bankruptcy judge this week that it wanted to re-open bidding for its assets after co-founder and ex-CEO Anne Wojcicki put forth a $305 million bid,

Regeneron Pharmaceuticals said on Monday it will buy genomics firm 23andMe Holding for $256 million through a bankruptcy auction, and promised to prioritize the ethical use of DNA data from customers using ancestry testing and other services.